Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Advances in Biochemical Engineering/Biotechnology|December 19, 2019
Aptamers in Diagnostic and Molecular Imaging ApplicationsVictoria Calzada
Cancers|February 11, 2023
Targeted-Lymphoma Drug Delivery System Based on the Sgc8-c AptamerEstefanía Sicco, Hugo Cerecetto, Victoria Calzada, et al.
Revista De Enfermeria (Barcelona, Spain)|June 8, 2012
[Descriptive study of intrapartum antibiotic prophylaxis of neonatal infection by group B Streptococcus in Txagorritxu]Leire Ordax García, M Victoria Calzada Hernández, Claudia Terrades Milla
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2023
Aptamer-Based Immunotheranostic StrategiesMaría Fernanda García Melián, María Moreno, Hugo Cerecetto, et al.
International Journal of Molecular Sciences|March 10, 2022
In Vivo Evaluation of Sgc8-c Aptamer as a Molecular Imaging Probe for Colon Cancer in a Mouse Xenograft ModelAna Paula Arévalo, Romina Castelli, Manuel Ibarra, et al.
Scientific Reports|October 8, 2021
Metastatic and non-metastatic melanoma imaging using Sgc8-c aptamer PTK7-recognizerEstefanía Sicco, Amy Mónaco, Marcelo Fernandez, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 15, 2020
Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological MalignanciesEstefanía Sicco, Jessica Baez, Manuel Ibarra, et al.
Current Radiopharmaceuticals|October 18, 2016
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for MelanomaXimena Camacho, Victoria Calzada, Marcelo Fernandez, et al.
World Journal of Nuclear Medicine|August 21, 2013
Labeling and Biological Evaluation of (99m)Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast CancerVictoria Calzada, Fernanda Garcia, Marcelo Fernández, et al.
Chemical Biology & Drug Design|October 29, 2017
Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizationsEstefanía Sicco, Jessica Báez, Jimena Margenat, et al.
Pageof 2